Youngevity International (NASDAQ:YGYI) issued its earnings results on Tuesday. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.40), MarketWatch Earnings reports. Youngevity International had a negative net margin of 10.85% and a negative return on equity of 150.83%. The business had revenue of $36.11 million for the quarter.
Youngevity International stock opened at $5.73 on Wednesday. Youngevity International has a fifty-two week low of $3.17 and a fifty-two week high of $16.25. The company has a debt-to-equity ratio of 1.62, a quick ratio of 0.29 and a current ratio of 0.79.
Several research analysts have recently weighed in on the stock. Benchmark upped their price target on shares of Youngevity International from $9.00 to $14.00 and gave the stock a “buy” rating in a report on Wednesday, February 13th. ValuEngine raised shares of Youngevity International from a “hold” rating to a “buy” rating in a report on Monday, February 4th.
An institutional investor recently bought a new position in Youngevity International stock. Geode Capital Management LLC purchased a new position in Youngevity International Inc (NASDAQ:YGYI) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 44,808 shares of the company’s stock, valued at approximately $256,000. Geode Capital Management LLC owned 0.17% of Youngevity International as of its most recent filing with the Securities and Exchange Commission (SEC). Hedge funds and other institutional investors own 3.06% of the company’s stock.
WARNING: This story was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this story on another site, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be viewed at https://www.thelincolnianonline.com/2019/04/17/youngevity-international-ygyi-announces-earnings-results.html.
Youngevity International Company Profile
Youngevity International, Inc develops and distributes health and nutrition related products and services through independent direct selling network in the United States and internationally. It operates in two segments, Direct Selling and Commercial Coffee. The company offers approximately 5,500 products, including nutritional, vitamin, mineral, herbal, liquid, and dietary supplements; apparel; fashion and jewelry accessories; digital products; and packaged foods.
Featured Story: Why is insider trading harmful?
Receive News & Ratings for Youngevity International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Youngevity International and related companies with MarketBeat.com's FREE daily email newsletter.